Teva pulls plans to market generic Lipitor

News | 29 May 2012

• Print This

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has decided not to market Atorvastatin, the generic version of Pfizer Inc. (NYSE: PFE) cholesterol-lowering drug Lipitor. According to a report from the "Economic Times of India", ...

Click on the link to read the full article at Globes
(This link will open in a new window)